Table 4.
The significant subpathways identified by ce‐Subpathway using breast cancer data set
| Subpathway ID | PathwayName | ce‐Subpathway (FDR) | Reference(PMID) |
|---|---|---|---|
| path:04630_6 | Jak‐STAT signalling pathway | 4.79E‐06 | 25104439; 30022447; 29383118 |
| path:04810_7 | Regulation of actin cytoskeleton | 3.07E‐05 | 23153535; 23775624 |
| path:04510_1 | Focal adhesion | 3.13E‐05 | 24491810; 25631868 |
| path:04510_6 | Focal adhesion | 3.13E‐05 | 24491810; 25631868 |
| path:04310_19 | Wnt signalling pathway | 0.0002 | 24606421; 25955111; 26129710 |
| path:05215_23 | Prostate cancer | 0.0002 | 25421124 |
| path:04010_11 | MAPK signalling pathway | 0.0003 | 24882719; 25066297 |
| path:04110_23 | Cell cycle | 0.0004 | 25064703; 24369047; 25407488 |
| path:04722_7 | Neurotrophin signalling pathway | 0.0004 | 28446206; 27467251 |
| path:00240_13 | Pyrimidine metabolism | 0.0009 | 29614418 |
| path:04630_2 | Jak‐STAT signalling pathway | 0.0012 | 25104439; 30022447; 29383118 |
| path:04350_26 | TGF‐β signalling pathway | 0.0106 | 25823021; 25217524; 26223118 |
| path:04510_24 | Focal adhesion | 0.0106 | 24491810; 25631868 |
| path:04530_3 | Tight junction | 0.0106 | 23934616; 29719617 |
| path:04010_10 | MAPK signalling pathway | 0.0154 | 24882719; 25066297 |
| path:04070_8 | Phosphatidylinositol signalling system | 0.0155 | 24774538; 25544707 |
| path:05220_25 | Chronic myeloid leukaemia | 0.0547 | 18192121 |
| path:04114_13 | Oocyte meiosis | 0.0574 | 28849078; 26804550 |